@PersimmonTI Idiots…Quite the self-own to fund a study showing your drug is equal to a competitor on actual hard endpoints (mortality and HF hospitalization)
@MysteriousMole1 1.) The dc rate in the 17.5mg arm was 1% 2.) Name the time a stock sold off in the mPFS>OS scenario you presented due to diarrhea or vomiting….The market is generally smarter than that.
@sadvalueinvestr@inwoodcapital Stop arguing with him. He has 500 substack subscribers, a much more impressive feat than scaling a fund (which only takes luck)